Exhibitors Search
CURSUS BIO

Booth no.
E41
Exhibition | PARTNERING |
---|---|
Country | Korea, South |
Address | 222 Wangsimni-ro, Seongdong-gu, Seoul, Republic of Korea |
Tel (Rep.) | 02-2220-4345 |
Website | http://cursusbio.com/ |
Company Introduction
Cursus Bio is a leading biotech company pioneering innovation in the treatment of obesity and metabolic diseases. We are developing next-generation gene-based obesity therapeutics that overcomes the limitations of existing GLP-1 analogs. By targeting adipocytes directly with a 'First-in-Class' mechanism, we are setting a new therapeutic paradigm. Our core asset, the MicroLock™ patch technology, is a proprietary transdermal drug delivery platform that enables the quantitative delivery of high-dose drugs. It has been validated to achieve efficacy comparable or superior to that of injectables, significantly improving patient access to obesity and metabolic disease treatments through a patient-friendly administration method. Furthermore, we have established a sustainable revenue model through our OEM/ODM business for microneedle cosmetics and pharmaceuticals, leveraging our CGMP-certified manufacturing facilities.
Promotional video
Exhibit Item
MicroArray Patch, Cosmetic and Medical Microneedle, Obesity Treatment, Gene Therapy
Exhibit Item Images
-
Product Name : Obesity Gene Therapy, MicroLock™ PatchOur obesity gene therapy, is a groundbreaking new drug that overcomes the limitations of existing GLP-1 treatments. By directly targeting adipocytes, it not only effectively reduces body weight but also prevents rebound weight gain. This "first-in-class" mechanism sets a new standard for obesity treatment.
Exhibit Description
Cursus Bio's main pipeline, obesity gene therapy, utilizes a differentiated mechanism from existing GLP-1-based treatments by directly targeting adipose cells, the root cause of obesity. It effectively reduces body weight and improves insulin sensitivity. Preclinical studies have demonstrated a 20% reduction in body weight and a weight loss.
Co-Exhibitor or
Partner’s Information
Company Name | Country |
---|---|